Skip to main content

Kouros Owzar

Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Integrative Genomics
Duke Box 2717, Durham, NC 27710
2424 Erwin Road, 7078 Hock Plaza, Durham, NC 27705

Selected Grants


Quantitative Methods for HIV/AIDS Research

Inst. Training Prgm or CMESteering Committee Member · Awarded by National Institute of Allergy and Infectious Diseases · 2018 - 2028

Single Cell and Spatial Analysis of Lethal Breast Cancers

ResearchCo Investigator · Awarded by Department of Defense · 2024 - 2028

Molecular Determinants of Health Disparities in Inflammatory Breast Cancer

ResearchCo Investigator · Awarded by National Cancer Institute · 2021 - 2026

New computational methods to dynamically pinpointing the subregions carrying disease-associated rare variants

ResearchCo Investigator · Awarded by National Human Genome Research Institute · 2022 - 2026

Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD

ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2026

Training Program in Bioinformatics at the Intersection of Cancer Immunology and Microbiome

ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2020 - 2025

Preoperative Breast Radiotherapy: A Tool to Provide Individualized and Biologically-Based Radiation Therapy

ResearchCollaborator · Awarded by Gateway for Cancer Research · 2015 - 2025

Ancestry-related RNA splicing and immune expression in metastatic breast cancer

ResearchCo Investigator · Awarded by Susan G. Komen Breast Cancer Foundation · 2022 - 2025

Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer

ResearchCollaborator · Awarded by Department of Defense · 2020 - 2022

Home Transplant to Preserve the Microbiota and Decrease GVHD

ResearchCollaborator · Awarded by American Society of Hematology · 2019 - 2022

Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer

ResearchCollaborator · Awarded by National Institutes of Health · 2020 - 2021

Profiling the Adenosine Axis in Metastatic Colorectal Cancer

ResearchStatistician · Awarded by MedImmune, Inc. · 2018 - 2021

Identification and validation of plasma-based protein biomarkers for cediranib and olaparib

ResearchCollaborator · Awarded by Leidos Biomedical Research, Inc. · 2019 - 2020

A hands-on, integrative next-generation sequencing course: design, experiment, and analysis

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2020

Pharmacogenomics of Microtubule Targeting Agents

ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2015 - 2020

Administrative Core

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2015 - 2020

Computational Resources and Dissemination Core

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2015 - 2020

Statistical/Computational Methods for Pharmacogenomics and Individualized Therapy

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2015 - 2020

Development of a Therapeutic for Brain Tumor Immunotherapy

ResearchBiostatistician Investigator · Awarded by National Institutes of Health · 2018 - 2019

Identification of Genetic Determinates for Disparities in African American Patients with Non-Small Cell Lung Cancer

ResearchSignificant Contributor · Awarded by V Foundation for Cancer Research · 2016 - 2018

Nanoplasmonics-based molecular analysis tool for molecular biomarkers of cancer

ResearchBiostatistician · Awarded by National Institutes of Health · 2015 - 2018

Predictive value of the IL6 pathway to direct anti-angiogenic therapy in advanced ovarian cancer

ResearchCollaborator · Awarded by American Association of Obstetricians and Gynecologists Foundation · 2017 - 2018

Pharmacogenomic Analysis of Alliance Breast Cancer Studies

ResearchPrincipal Investigator · Awarded by Alliance for Clinical Trials in Oncology Foundation · 2015 - 2017

National Clinical Trials Network - Network Group Statistics and DMCs

ResearchStatistician · Awarded by Mayo Clinic · 2014 - 2017

(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies

ResearchPrincipal Investigator · Awarded by Cornell University · 2015 - 2017

Biomarker Discovery to Direct Bevacizumab Therapy in Ovarian Cancer - Blood-based Angiome Profiling

ResearchStatistician · Awarded by National Institutes of Health · 2014 - 2017

PAAR Pharmacogenomics of Anticancer Agents Research Group

ResearchPrincipal Investigator · Awarded by University of Chicago · 2010 - 2015

(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2014 - 2015

Computational Resources and Dissemination Core

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2010 - 2015

Poly-functional analyses of vaccine-induced T cell responses

ResearchStatistician · Awarded by National Institutes of Health · 2001 - 2012

Cancer and Leukemia Group B Statistical Center

ResearchStatistician · Awarded by National Institutes of Health · 1982 - 2010

mTOR Therapy in Prostate Cancer: Signatures of Response and Biology of Resistance

ResearchStatistician · Awarded by National Institutes of Health · 2007 - 2010

External Relationships


  • University of North Carolina at Chapel Hill

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.